SM
VXRT

Sabby Management’s Vaxart VXRT Stock Holding History

Sabby Management’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,197,710
Closed -$430K – 89
2019
Q3 		$430K Buy
1,197,710
+277,063
+30% +$181K 0.23% 44
2019
Q2 		$617K Buy
920,647
+723,646
+367% +$606K 0.78% 27
2019
Q1 		$382K Buy
+197,001
New +$375K 0.18% 41

Other funds holding VXRT

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Carlson Capital Management Northfield, Minnesota $2.29B AUM 7.48% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
RFWA
RPg Family Wealth Advisory Burlington, Massachusetts $479M AUM 25.83% 1-Year Est. Return

Sabby Management's VXRT Position: Q4 2019 in Review

Sabby Management sold out of Vaxart (VXRT) in Q4 2019, closing a stake of 1,197,710 shares — an estimated $430K sold.

Sabby Management first reported a position in VXRT in Q1 2019 and held it in 3 quarters. The position peaked at $617K in Q2 2019. 20 funds tracked by Wall St. Rank hold VXRT as of Q4 2019.

  • Sabby Management reported no remaining Vaxart position as of Q4 2019 after selling out during the quarter.
  • Sabby Management sold 1,197,710 Vaxart shares in Q4 2019, an estimated $430K.
  • Sabby Management first reported a position in Vaxart in Q1 2019 and held it in 3 quarters.
  • Sabby Management's Vaxart position peaked at $617K in Q2 2019.
  • 20 funds tracked by Wall St. Rank held Vaxart as of Q4 2019.

Based on Sabby Management's 13F filing for Q4 2019, filed 14 Feb 2020.